This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1vrw

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1vrw.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1vrw.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1vrw| PDB=1vrw | SCENE= }}
{{STRUCTURE_1vrw| PDB=1vrw | SCENE= }}
-
'''Crystal structure analysis of plasmodium falciparum enoyl-acyl-carrier-protein reductase with nadh'''
+
===Crystal structure analysis of plasmodium falciparum enoyl-acyl-carrier-protein reductase with nadh===
-
==Overview==
+
<!--
-
The human malaria parasite Plasmodium falciparum synthesizes fatty acids using a type II pathway that is absent in humans. The final step in fatty acid elongation is catalyzed by enoyl acyl carrier protein reductase, a validated antimicrobial drug target. Here, we report the cloning and expression of the P. falciparum enoyl acyl carrier protein reductase gene, which encodes a 50-kDa protein (PfENR) predicted to target to the unique parasite apicoplast. Purified PfENR was crystallized, and its structure resolved as a binary complex with NADH, a ternary complex with triclosan and NAD(+), and as ternary complexes bound to the triclosan analogs 1 and 2 with NADH. Novel structural features were identified in the PfENR binding loop region that most closely resembled bacterial homologs; elsewhere the protein was similar to ENR from the plant Brassica napus (root mean square for Calphas, 0.30 A). Triclosan and its analogs 1 and 2 killed multidrug-resistant strains of intra-erythrocytic P. falciparum parasites at sub to low micromolar concentrations in vitro. These data define the structural basis of triclosan binding to PfENR and will facilitate structure-based optimization of PfENR inhibitors.
+
The line below this paragraph, {{ABSTRACT_PUBMED_11792710}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 11792710 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_11792710}}
==About this Structure==
==About this Structure==
Line 33: Line 37:
[[Category: Rossmann fold]]
[[Category: Rossmann fold]]
[[Category: Short chain dehydrogenase reductase]]
[[Category: Short chain dehydrogenase reductase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 12:50:55 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 13:17:15 2008''

Revision as of 10:17, 28 July 2008

Image:1vrw.png

Template:STRUCTURE 1vrw

Crystal structure analysis of plasmodium falciparum enoyl-acyl-carrier-protein reductase with nadh

Template:ABSTRACT PUBMED 11792710

About this Structure

1VRW is a Single protein structure of sequence from Plasmodium falciparum. This structure supersedes the now removed PDB entry 1nhd. Full crystallographic information is available from OCA.

Reference

Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase., Perozzo R, Kuo M, Sidhu AS, Valiyaveettil JT, Bittman R, Jacobs WR Jr, Fidock DA, Sacchettini JC, J Biol Chem. 2002 Apr 12;277(15):13106-14. Epub 2002 Jan 15. PMID:11792710

Page seeded by OCA on Mon Jul 28 13:17:15 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1vrw"
Personal tools